Latest Commercialization News

Adherium Limited’s iCARE study reports unprecedented medication adherence improvements and sustained patient engagement in COPD and asthma care, highlighting significant clinical and economic benefits.

Northern Minerals has released its Definitive Feasibility Study for the Browns Range Heavy Rare Earth Project, confirming an 11-year production plan targeting 181,000 tonnes of rare earth concentrate. The project aims to establish a critical Australian supply chain for heavy rare earths in partnership with Iluka Resources.

TMK Energy has successfully raised $3.5 million through an oversubscribed placement, setting the stage for commercial production and exploration at its Gurvantes XXXV Coal Seam Gas Project.

Artrya Limited has completed the first tranche of its A$75 million placement, raising approximately A$60 million to advance its AI-driven coronary artery disease platform. Eligible shareholders can now participate in a Share Purchase Plan at the same price.

Cleo Diagnostics has received encouraging feedback from the U.S. FDA on its ovarian cancer pre-surgical triage test, reinforcing its clinical trial design and regulatory strategy ahead of a critical 510(k) submission.

Kinetiko Energy has achieved a record peak gas flow from its latest production test well at Brakfontein, significantly surpassing previous results and advancing its pilot LNG project in South Africa.

Zeotech Limited has locked in a binding five-year offtake agreement with MSI, granting exclusive marketing rights for its kaolin products across key Asian markets. This deal, valued at approximately AUD 204 million, sets the stage for early cash flow generation and advancement of its low-carbon concrete additive project.

Bioxyne Limited has secured import permits and purchase orders worth A$5.1 million for medical cannabis in Germany, signaling strong early traction in a key European market.

Actinogen Medical has reached a pivotal agreement with the US FDA outlining the regulatory and clinical trial requirements for Xanamem’s approval in Alzheimer’s disease, setting a clear path toward a US marketing application.

Clara Resources has upgraded the Ashford coking coal project’s resource classification to Measured status, reinforcing confidence in the deposit and setting the stage for a Pre-Feasibility Study to validate mining and financial assumptions.

InteliCare Holdings has raised $2 million through a two-tranche placement to accelerate its AI-driven aged care platform and terminated a convertible note facility to streamline its capital base.

AVITA Medical has secured the CE Mark for its innovative RECELL GO device, paving the way for commercialization across key European markets including Germany, Italy, and the UK. This regulatory milestone expands the company’s footprint in acute wound care.